Patent · US Active

Complex

US12059471B2 · kind B2 · utility

0Cited by
0References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 9, 2021
Grant dateAug 13, 2024
Priority date
Expiry dateOct 23, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/55583
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An object is to provide a technique of forming CpG oligonucleotides and hydrophobized polysaccharides into complexes. This object is achieved by a complex comprising a modified CpG oligonucleotide containing a hydrophobic group A having a sterol skeleton, and a modified polysaccharide containing a hydrophobic group B.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.